Conversion of waste biomass to value-added carbon is an environmentally benign utilization of waste biomass to reduce greenhouse gas emissions and air pollution caused by open burning. In this study, various waste biomasses are converted to capacitive carbon by a single-step molten salt carbonization (MSC) process. The as-prepared carbon materials are amorphous with oxygen-containing functional groups on the surface. For the same type of waste biomass, the carbon materials obtained in Na2CO3-K2CO3 melt have the highest Brunauer-Emmett-Teller (BET) surface area and specific capacitance. The carbon yield decreases with increasing reaction temperature, while the surface area increases with increasing carbonization temperature. A working temperature above 700 °C is required for producing capacitive carbon. The good dissolving ability of alkaline carbonate molten decreases the yield of carbon from waste biomasses, but helps to produce high surface area carbon. The specific capacitance data confirm that Na2CO3-K2CO3 melt is the best for producing capacitive carbon. The specific capacitance of carbon derived from peanut shell is as high as 160 F g(-1) and 40 μF cm(-2), and retains 95% after 10,000 cycles at a rate of 1 A g(-1). MSC offers a simple and environmentally sound way for transforming waste biomass to highly capacitive carbon as well as an effective carbon sequestration method.
During acute and chronic inflammatory lung diseases, the normal fibrinolytic activity in the alveolar space is inhibited by increased levels of plasminogen activator inhibitor 1 (PAI-1). Transgenic mice having increased fibrinolytic activity due to genetic deficiency of PAI-1 develop less fibrosis after bleomycin-induced lung inflammation. These observations led us to hypothesize that pulmonary fibrosis could be limited through enhancement of alveolar fibrinolytic activity by adenovirus-mediated transfer of the urokinase-type plasminogen activator (uPA) gene to the lung. To investigate this hypothesis, 0.075 U of bleomycin was introduced intratracheally into mice. Twenty-one days later, the mice were treated intratracheally with phosphate-buffered saline (PBS), a control adenovirus, or adenoviruses containing murine or human uPA cDNAs. On day 28, the mice were sacrificed, and lung fibrosis was quantitated by measuring hydroxyproline content. As expected, bleomycin caused a doubling in lung hydroxyproline to 345.6+/-28.2 microg/lung (SEM) compared with mice receiving PBS (170.2+/-4.0 microg/lung). Treatment of the bleomycin-injured mice with the control adenovirus on day 21 had no impact on lung fibrosis (338.4+/-17.2 microg/lung). Importantly, the human uPA adenovirus significantly reduced (p<0.05) lung hydroxyproline (281.2+/-22.8 microg/lung), thus attenuating by 38% the bleomycin-induced increase in lung collagen. The improvement in bleomycin-induced lung fibrosis resulting from treatment with the human uPA adenovirus further supports the importance of the fibrinolytic system during inflammatory lung injury and repair.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.